Research Grade Rinucumab (DHC42201)

Catalog No.

DHC42201

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG4-kappa

Clonality

Monoclonal

Target

Beta-type platelet-derived growth factor receptor, Beta platelet-derived growth factor receptor, CD140b, Platelet-derived growth factor receptor 1, PDGFRB, PDGF-R-beta, Platelet-derived growth factor receptor beta, CD140 antigen-like family member B, PDGFR-1, PDGFR1, PDGFR-beta, PDGFR

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P09619

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

REGN-2176, REGN-2176-3 (combination of aflibercept and ricunumab), REGN2176, CAS: 1569263-06-4

Clone ID

Rinucumab

An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications, PMID: 28195611

Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration, PMID: 28756707

Document Download

Research Grade Rinucumab.pdf